China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm owns a GMP-certified plant and production facilities and has the capacity to produce 21 different NMPA-approved medicines, 14 NMPA-approved health supplement products and 8 hemp derivative products in soft capsule, hard capsule, tablet, granule, oral liquid forms. These products address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.
Follow-Up Questions
China Health Industries Holdings Inc 'in CEO'su kimdir?
Mr. Xin Sun 2007 'den beri şirketle birlikte olan China Health Industries Holdings Inc 'in Chairman of the Board 'ıdır.
CHHE hissesinin fiyat performansı nasıl?
CHHE 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
China Health Industries Holdings Inc için ana iş temaları veya sektörler nelerdir?
China Health Industries Holdings Inc Consumer products endüstrisine ait ve sektör Consumer Staples 'dir
China Health Industries Holdings Inc 'in piyasa değerlemesi nedir?
China Health Industries Holdings Inc 'in mevcut piyasa değerlemesi $0 'dir
